LINKEDINCOMMENTMORE

NEW YORK - Stock futures were pointing to a flat open on Wall Street Tuesday, following disappointing results from food giant Coca-Cola and the news of a large merger in the pharmaceutical sector.

KEEPING SCORE: The Dow Jones industrial average futures were down a point to 16,126 as of 9 a.m. Eastern. The Standard & Poor s 500 index futures lost less than a point to 1,834 and the Nasdaq futures were up a point to 3,662.00.

M&A IN PHARMACEUTICALS: Drugmaker Forest Laboratories was up 30 percent in premarket trading after another drugmaker, Actavis, agreed to buy it for $25 billion. Actavis makes the generic versions of hyperactivity disorder medication Concerta and cholesterol drug Lipitor, while Forest makes the Alzheimer s disease treatment Namenda.

COCA-COLA LOSES FIZZ:The beverage giant was down more than 2 percent in premarket trading after reporting a decline in fourth-quarter profit and sales from a year ago.

Read or Share this story: http://www.khou.com/story/money/business/2014/07/24/12372144/